Neuroprosthesis serves as communication aid for ALS patient for 7 years

Date:
neuroprothese

A neuroprosthesis enabled an ALS patient to communicate independently for seven years, showing the long-term potential of brain-computer interfaces.

In 2015, a team at UMC Utrecht treated a woman with ALS by implanting a neuroprosthesis to help her communicate. Now, in a new publication, the Utrecht team shows for the first time that this neuroprosthesis was successfully used independently at home over a period of seven years. It served as the participant’s primary communication tool and became fully integrated into her daily life. This demonstrates that neuroprostheses can enable patients to communicate more effectively and maintain control over their lives for a longer time, until the disease progresses to a point where even the prosthesis can no longer provide support.

The results of the research, lead by Mariska van Steensel and Nick Ramsey, can be found in the New England Journal of Medicine.

ALS is een progressieve spierziekte

People with ALS face a poor prognosis. The disease progressively affects more muscles, eventually making movement, communication, and ultimately life itself impossible. In the final stage, a patient may develop Locked-In Syndrome, in which no form of communication is possible anymore.

The neuroprosthesis as a solution

To compensate for the progressive decline, researchers at UMC Utrecht are working on the development of neuroprostheses, also known as Brain-Computer Interfaces (BCIs). A neuroprosthesis consists of electrodes implanted in the brain that pick up signals. These signals are then translated via a computer connection into commands for operating a computer, such as a mouse click. This enables a patient to continue communicating even after the onset of Locked-In Syndrome.

How long does a neuroprosthesis work?

For the first time, the UMC Utrecht team conducted a long-term study on an ALS patient who received a neuroprosthesis. The study showed promising results. Mariska: “Our participant used the system independently for seven years, and for several of those years it was her only way of alerting her caregiver, both during the day and at night.” The device itself continued functioning well. Only when the disease had progressed to the point that the brain could no longer send strong signals did the neuroprosthesis stop being effective.

While the disease cannot be halted with a neuroprosthesis, the technology can still make a crucial difference in the quality of life and autonomy of people with ALS, even in later stages. “As long as the brain is able to send a message, the system works—and it can make a tremendous difference in the lives of these patients and their families,” says Mariska.

Neuroprostheses are becoming more accessible

The development of neuroprostheses is advancing rapidly, with significant investment being made. It is expected that in the coming years, these devices will become widely available and can be used to help people with severe communication impairments caused by ALS or other conditions. This is also reflected in the current edition of the New England Journal of Medicine, which features a second article on BCIs. “In that other study, a person in an earlier stage of ALS was able to communicate quickly and accurately using a BCI. This shows that BCIs can also be valuable for people with less severe impairments.”

Furthermore, (new) treatments that slow the progression of ALS are likely to extend the period in which a BCI can be useful.

“We are currently working on improved versions of the technology and hope to demonstrate its value as a communication tool in the daily lives of these patients in our new projects: CORTICOM, INTENSE, and INTRECOM,” Mariska concludes.

Source: UMC Utrecht

 

LSI

Laigo Bio at Utrecht Science Park raises €11.5 million in investments

Laigo Bio, a start-up located at Utrecht Science Park in the Life Sciences Incubator building, announced today that it has raised €11.5 million in investments from a large number of leading investors.

Nieuwbouw Ronald McDonald

Ronald McDonald House Utrecht presents plans for new, larger House with 50 rooms

Ronald McDonald House Utrecht is building for the future. At Utrecht Science Park, next to the Wilhelmina Children’s Hospital and within walking distance of the Princess Máxima Center, Ronald McDonald House Utrecht has advanced plans to build a brand new, sustainable House with 50 guest rooms. Preparations are well underway, and construction is scheduled to begin in the second half of 2026. The goal is to open the new House sometime in 2028. This expansion will allow the House to offer more families of seriously ill or care-intensive children a warm home, allowing them to be close to their sick child day and night.

Johan Garssen Onderscheiding Leslie Hondebrink

French honour for nutrition scientist Johan Garssen

Researcher Johan Garssen has been appointed Officier in the Ordre du Mérite agricole by the French government. He receives this prestigious honor for his exceptional contributions to agriculture, nutrition, health and international collaboration. The decoration was presented today by the French Ambassador to the Netherlands.